IRIS

4.2 Abstract in Atti di convegno: [990] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 661 a 680 di 990
Titolo Data di pubblicazione Autore(i) File
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Perrino, M; Bertossi, M; Giordano, L; Santoro, A
Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with solid tumors 1-gen-2011 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C; Santoro, A
Three-day low-dose Cisplatin administration in advanced non-small cell lung cancer (NSCLC): Efficacy and reduced toxicity 1-gen-2004 Frontini, L; Ardizzoia, A; Pressiani, T; Colombo, I; Simonelli, M; Vaghi, M; Lissoni, P; Gardani, G
Final results from ARQ 197-114: A phase 1b safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC) 1-gen-2010 Zucali, P; Santoro, A; Rodriguez-Lope, C; Simonelli, M; Camacho, Lh; Senzer, Nn; Bolondi, L; Lamar, M; Abbadessa, G; Schwartz, Be
Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control 1-gen-2014 Simonelli, M; Denlinger, Cs; Goff, Lw; Noberasco, C; Kim, Ty; Thomas, Mb; De Braud, Fg; Zucali, Pa; Santoro, A; English, Pa; Gallo-Stampino, C; Wang, Ej; Carpentieri, M; Williams, Ja
Vinorelbine as Second or Third-Line Therapy in Pemetrexed-Pretreated Malignant Pleural Mesothelioma (MPM) Patients 1-gen-2015 Ceresoli, Gl; Zucali, Pa; Grosso, F; Mencoboni, M; Bonomi, P; Parra, Hjms; Pasello, G; Cortinovis, D; Perrino, M; Muzio, A; Bruzzone, A; De Vincenzo, F; Degiovanni, D; Simonelli, M; Beretta, Gd; Giordano, L; Santoro, A
PHASE I AND PHARMACODYNAMIC STUDY OF NGR-HTNF ADMINISTERED AT HIGH DOSES IN REFRACTORY PATIENTS WITH SOLID TUMORS 1-gen-2010 Zucali, Pa; Santoro, A; Simonelli, M; De Vincenzo, F; Lorenzi, E; Rimassa, L; Balzarini, L; Quagliuolo, V; Lambiase, A; Bordignon, C
Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF 1-gen-2013 Zucali, Pa; Simonelli, M; De Vincenzo, F; Santoro, A; Lambiase, A; Bordignon, C
Tivantinib in combination with gemcitabine shows strong antitumor activity on mesothelioma cell lines and cytoskeletal effects via inhibition of actin 1-gen-2014 Simonelli, M; Zucali, R; Suter, M; Rubino, L; Santoro, A; Carlo-Stella, C
Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028 1-gen-2015 Ott, Pa; Piha-Paul, Sa; Munster, P; Pishvaian, Mj; Van Brummelen, E; Cohen, R; Gomez-Roca, C; Ejadi, S; Stein, M; Chan, E; Simonelli, M; Morosky, A; Yuan, Ss; Koshiji, M; Bennouna, J
IMPACT OF SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS (STNF-RS) SHEDDING ON OUTCOME IN PATIENTS TREATED WITH NGR-HTNF 1-gen-2012 Zucali, Pa; Simonelli, M; De Vincenzo, F; Lorenzi, E; Santoro, A; Lambiase, A; Bordignon, C
Vinorelbine as second or third-line therapy in pemetrexed-pretreated malignant pleural mesothelioma (MPM) patients 1-gen-2015 Ceresoli, Gl; Zucali, Pa; Grosso, F; Mencoboni, M; Sauta, Mg; Parra, Hjs; Pasello, G; Cortinovis, D; Perrino, M; Muzio, A; Bruzzone, A; De Vincenzo, F; Degiovanni, D; Bonomi, M; Simonelli, M; Beretta, Gd; Giordano, L; Santoro, A
Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study 1-gen-2010 De Vincenzo, F; Zucali, P; Ceresoli, G; Gianoncelli, L; Lorenzi, E; Simonelli, M; Ripa, C; Giordano, L; Santoro, A
MODULATION OF IL-2 CANCER IMMUNOTHERAPY BY CYCLOOXYGENASE (COX)-2 INHIBITORS: THERAPEUTIC AND BIOLOGICAL RESULTS OF IL-2 PLUS CELECOXIB IN METASTATIC RENAL CELL CANCER (RCC) PROGRESSING ON IL-2 ALONE 1-gen-2004 Lissoni, P; Vaghi, M; Frontini, L; Ardizzoia, A; Pressiani, T; Colombo, I; Simonelli, M; Gardani, G
The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin 1-gen-2009 Zucali, P; Destro, A; Ceresoli, Gl; Gianoncelli, L; Lorenzi, E; De Vincenzo, F; Simonelli, M; Giordano, L; Roncalli, M; Santoro, A
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 1-gen-2014 Lopci, E; Bello, L; Olivari, L; Raneri, F; Simonelli, M; Riva, M; Navarria, P; Zucali, Pa; Colombo, P; Scorsetti, M; Santoro, A; Chiti, A
Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC) 1-gen-2013 Simonelli, M; Zucali, Pa; Thomas, Mb; Brisendine, A; Berlin, J; Noberasco, C; Denlinger, Cs; Kim, Ty; Santoro, A; Gallo-Stampino, C; Carpentieri, M; Wang, Ej; Williams, Ja; De Braud, Fg
Pharmacodynamic (PD) evaluation of soluble proteins from a phase I trial of lapatinib (L) in combination with sorafenib (S) 1-gen-2012 Simonelli, M; Zucali, Pa; Lorenzi, E; Rubino, L; De Vincenzo, F; Perrino, M; Rimassa, L; Giordano, L; Santoro, A
Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM) 1-gen-2014 Zucali, Pa; Simonelli, M; De Vincenzo, F; Fatuzzo, G; Bertossl, M; Suter, Mb; Perrino, M; Giordano, L; Santoro, A
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mg; Zuradelli, M; Giordano, L; Santoro, A
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 661 a 680 di 990
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 4 Contributo in Atti di Convegno ...990
Autore
  • Marcacci, Maurilio181
  • EVANGELISTA, LAURA125
  • CIVILINI, EFREM73
  • LEVI SETTI, PAOLO EMANUELE65
  • KON, ELIZAVETA63
  • VINCIGUERRA, PAOLO59
  • ASSELTA, ROSANNA56
  • DUGA, STEFANO51
  • Fiorino, Gionata37
  • D'INCALCI, MAURIZIO36
Data di pubblicazione
  • 2020 - 202322
  • 2010 - 2019516
  • 2000 - 2009346
  • 1990 - 199980
  • 1980 - 198926
Editore
  • s.n110
  • sn21
  • Società Italiana di Fisiologia7
  • Monduzzi Editore5
  • Springer5
  • AMER SOC CLINICAL ONCOLOGY, 2318 ...3
  • COFESE EDIZIONI PALERMO3
  • Hungarian Society of Sport Science2
  • IMECHE2
  • ISAKOS2
Rivista
  • ANNALS OF ONCOLOGY27
  • JOURNAL OF CLINICAL ONCOLOGY22
  • GASTROENTEROLOGY20
  • EUROPEAN JOURNAL OF CANCER13
  • JOURNAL OF CROHN'S AND COLITIS10
  • KNEE SURGERY, SPORTS TRAUMATOLOGY...10
  • NEURO-ONCOLOGY10
  • EUROPEAN RESPIRATORY JOURNAL SUPP...8
  • INTERNATIONAL JOURNAL OF GYNECOLO...7
  • CANCER RESEARCH6
Serie
  • IEEE ENGINEERING IN MEDICINE AND ...1
Keyword
  • acl reconstruction11
  • pneumonia8
  • follow-up4
  • knee4
  • navigation system4
  • ACL RECONSTRUCTION3
  • CPAP3
  • double bundle3
  • failure3
  • lca3
Lingua
  • eng486
  • ita173
  • fre7
  • und3
Accesso al fulltext
  • no fulltext963
  • reserved27